ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

October 10, 1980

In Brief: Hatch Introduces Bill Banning Smoking On U.S. Public Conveyances; New OCC Staff Announced

January 16, 1987

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001

ACS Executive Proposes Efficiency Plan, Critics Fear Erosion Of Local Influence

May 1, 1998

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977